Consider this:
- The clinical evidence for one technology does not necessarily apply to another.
- Each cerebral oximeter uses unique methodologies, algorithms and sensor design to analyze the oxy-haemoglobin saturation in tissue.
- The clinical evidence supporting the INVOS™ system is specific to INVOS™ technology and does not reflect the performance of competitive products.